Gloom continues for equities
Australian superannuation fund members will have received little good news in November, with the latest Mercer sector surveys revealing both Australian and international equities posted broadly negative results during the month.
According to Mercer, November saw the Australian share market maintain its downward trend, with the S&P/ASX 300 falling 6.3 per cent over the month, following massive sell-offs in October and September.
The Mercer analysis said small cap stocks had declined by 9.6 per cent during November, substantially underperforming their large cap counterparts, which declined only 5.8 per cent.
Looking at international equities, the Mercer analysis said the MSCI World ex-Australia index had declined by 6.1 per cent in local currency terms, with several large countries slipping into recession and banks continuing to report losses.
However, it said the last week of November saw the market reverse, with Governments across the world introducing rescue packages and the US Government’s bailout of Citigroup helping to improve sentiment.
Recommended for you
Global X has painted a worrying picture for active ETFs in Australia, with investor adoption proving uneven and the popularity of its low-cost index counterparts only growing stronger.
Australian equity ETFs attracted record inflows of $3.2 billion in 1Q25, while heightened volatility led to a decline in flows for global equity ETFs, according to Vanguard.
The failure of a clinical trial by biotech firm Opthea has caused shares in its backer Regal Partners to decline 52 per cent year-to-date and hit its funds under management, quarterly flows show.
GQG Partners has revealed its quarterly flows for the first three months of 2025 were up 5.8 per cent, after a difficult final quarter of 2024 as a result of institutional redemptions.